SEARCH

SEARCH BY CITATION

References

  • Cesana, C., Klersy, C., Barbarano, L., Nosari, A.M., Crugnola, M., Pungolino, E., Gargantini, L., Granata, S., Valentini, M. & Morra, E. (2002) Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Journal of Clinical Oncology, 20, 16251634.
  • Davies, F.E., Rawstron, A.C., Owen, R.G. & Morgan, G.J. (2002) Minimal residual disease monitoring in multiple myeloma. Best Practice & Research. Clinical Haematology, 15, 197222.
  • Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. & Kuramoto, A. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81, 26582663.
  • International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. British Journal of Haematology, 121, 749757.
  • Kyle, R.A., Therneau, T.M., Rajkumar, S.V., Offord, J.R., Larson, D.R., Plevak, M.F. & Melton, L.J. III (2002) A long-term study of prognosis in monoclonal gammopathy of undetermined significance. New England Journal of Medicine, 346, 564569.
  • Mateo, M.G., Miguel Izquierdo, J.F. & Orfao, A. (2005) Immunophenotyping of plasma cells in multiple myeloma. Methods in Molecular Medicine, 113, 524.
  • Ocqueteau, M., Orfao, A., Almeida, J., Bladé, J., González, M., García-Sanz, R., López-Berges, C., Moro, M.J., Hernández, J., Escribano, L., Caballero, D., Rozman, M. & San Miguel, J.F. (1998) Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. American Journal of Pathology, 152, 16551665.
  • Paiva, B., Vidriales, M.B., Cerveró, J., Mateo, G., Pérez, J.J., Montalbán, M.A., Sureda, A., Montejano, L., Gutiérrez, N., Garcia de Coca, A., Heras, N., Mateos, M.V., López-Berges, C., García-Boyero, R., Galende, J., Hernández, J., Palomera, L., Carrera, D., Martínez, R., De La Rubia, J., Martín, A., Bladé, C.J., Orfao, A. & San Miguel, J.F. (2008) Multiparameter flow cytometry remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood, 112, 40174023.
  • Pérez-Persona, E., Vidriales, M.B., Mateo, G., García-Sanz, R., Mateos, M.V., García de Coca, A., Galende, J., Martín-Nuñez, G., Alonso, J.M., De Las Heras, N., Hernández, J.M., Martín, A., López-Berges, C., Orfao, A. & San Miguel, J.F. (2007) New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood, 110, 25862592.
  • Rajkumar, S.V. (2005) MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Hematology, 2005, 340345.
  • Rawstron, A.C., Orfao, A., Beksac, M., Bezdickova, L., Brooimans, R.A., Bumbea, H., Dalva, K., Fuhler, G., Gratama, J., Hose, D., Kovarova, L., Lioznov, M., Mateo, G., Morilla, R., Mylin, A.K., Omede, P., Pellat-Deceunynck, C., Pérez, A.M., Petrucci, M., Ruggeri, M., Rymkiewicz, G., Schmitz, A., Schreder, M., Seynaeve, C., Spacek, M., De Tute, R.M., Van Valckenborgh, E., Weston-Bell, N., Owen, R.G., San Miguel, J.F., Sonneveld, P. & Johnsen, H.E. (2008) Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica, 93, 431438.
  • Rosiñol, L., Bladé, J., Esteve, J., Aymerich, M., Rozman, M., Montoto, S., Gine, E., Nadal, E., Filella, X., Queralt, R., Carrio, A. & Montserrat, E. (2003) Smoldering multiple myeloma: natural history and recognition of an evolving type. British Journal of Haematology, 123, 631636.
  • Rosiñol, L., Carrio, A., Bladé, J., Queralt, R., Aymerich, M., Cibeira, M.T., Esteve, J., Rozman, M., Campo, E. & Montserrat, E. (2005) Comparative genomic hybridisation identifies two variants of smoldering multiple myeloma. British Journal of Haematology, 130, 729732.
  • San Miguel, J.F., Almeida, J., Mateo, G., Bladé, J., López-Berges, C., Caballero, D., Hernández, J., Moro, M.J., Fernández-Calvo, J., Díaz-Mediavilla, J., Palomera, L. & Orfao, A. (2002) Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome. Blood, 99, 18531856.
  • Weber, D.M., Dimopoulos, M.A., Moulopoulos, L.A., Delasalle, K.B., Smith, T. & Alexanian, R. (1997) Prognostic features of asymptomatic multiple myeloma. British Journal of Haematology, 97, 810814.